Skip to main content
Egyptian Liver Journal

Table 4 Comparison between the three investigation groups based on serum AFP levels (ng/ml)

From: Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma

 

Group I (n = 30)

Group II (n = 30)

Group III (n = 30)

H

p

Serum AFP (ng/ml)

 Min.–max.

2.90–22.0

4.0–22000.0

1.90–7.80

45.942*

< 0.001*

 Mean ± SD

8.16 ± 5.41

3488.8 ± 6181.5

4.62 ± 1.90

 Median (IQR)

6.30 (4.4–10.0)

295.0 (12.0–1900.0)

5.0 (3.0–6.2)

Sig. bet. grps.

p1 < 0.001*, p2 = 0.034*, p3 < 0.001*

  
  1. IQR Interquartile range. SD Standard deviation. H H for Kruskal-Wallis test. The post hoc test, commonly known as the Dunn’s test for multiple comparisons, was used to compare the two groups in pairs. p p-value to compare the three study involved groups. p1 p-value to compare group I and group II. p2 p-value to compare group I and group III. p3 p-value to compare group II and group III. *Statistical significance at p ≤ 0.05. Group I, individuals diagnosed with cirrhosis but no HCC. Group II, cirrhotic individuals with HCC. Group III, healthy controls
Back to article page